- Home
- OVLY vs ELDN Comparison
OVLY vs ELDN Comparison
Compare OVLY & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVLY
- ELDN
- Stock Information
- Founded
- OVLY 1990
- ELDN 2004
- Country
- OVLY United States
- ELDN United States
- Employees
- OVLY N/A
- ELDN N/A
- Industry
- OVLY Major Banks
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- OVLY Finance
- ELDN Health Care
- Exchange
- OVLY Nasdaq
- ELDN Nasdaq
- Market Cap
- OVLY 218.4M
- ELDN 202.4M
- IPO Year
- OVLY N/A
- ELDN N/A
- Fundamental
- Price
- OVLY $26.37
- ELDN $3.49
- Analyst Decision
- OVLY
- ELDN Strong Buy
- Analyst Count
- OVLY 0
- ELDN 2
- Target Price
- OVLY N/A
- ELDN $12.50
- AVG Volume (30 Days)
- OVLY 19.2K
- ELDN 780.9K
- Earning Date
- OVLY 07-18-2025
- ELDN 08-18-2025
- Dividend Yield
- OVLY 2.27%
- ELDN N/A
- EPS Growth
- OVLY N/A
- ELDN N/A
- EPS
- OVLY 2.92
- ELDN N/A
- Revenue
- OVLY $79,674,000.00
- ELDN N/A
- Revenue This Year
- OVLY N/A
- ELDN N/A
- Revenue Next Year
- OVLY N/A
- ELDN N/A
- P/E Ratio
- OVLY $8.97
- ELDN N/A
- Revenue Growth
- OVLY 4.08
- ELDN N/A
- 52 Week Low
- OVLY $22.70
- ELDN $2.38
- 52 Week High
- OVLY $32.24
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- OVLY 41.12
- ELDN 47.79
- Support Level
- OVLY $26.03
- ELDN $3.12
- Resistance Level
- OVLY $28.24
- ELDN $3.47
- Average True Range (ATR)
- OVLY 0.53
- ELDN 0.26
- MACD
- OVLY -0.22
- ELDN -0.06
- Stochastic Oscillator
- OVLY 18.15
- ELDN 33.32
About OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.